Professor
Tel Aviv University
Head, Haemato-oncology and Cord Blood Bank, Chaim Sheba, Israel
Prof. Arnon Nagler has a long history of research in hematology, including non-myeloablative and RIC allogeneic HSCT in malignant and non-malignant hematologic diseases. He founded Israel's first public cord blood bank and led Israel's first cord blood HSCT for hereditary and malignant haematological diseases with matched and unrelated donors. He has served on the editorial boards of several journals in the field such as Leukemia, and currently serves as Associate Editor of Bone Marrow Transplantation and on the editorial boards of several journals on the subject of blood and haematopoietic stem cell transplantation. He and his research team have published more than 1000 papers, including in top journals such as Journal of Clinical Oncology and Blood.
Beider K, et al. J Hematol Oncol. 2022
Sanz J et al., J Hematol Oncol. 2021
Dholaria B., J Hematol Oncol. 2021
Nagler A., J Hematol Oncol. 2021
Shouval R, et al., Lancet Haematol. 2021
Beider K, et al., J Hematol Oncol. 2020
Brissot E, et al., J Hematol Oncol. 2020
Piemontese S et al., J Hematol Oncol. 2019
Shouval R, et al., Lancet Haematol. 2019
Battipaglia G et al., Blood. 2019
Malard F et al., J Hematol Oncol. 2018
Cell Research
The First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang Society for Immunology
Liangzhu Laboratory
© Copyright Cell Research Symposium - All rights reserved.